Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
IDIBAPS is promoting different programs to facilitate professionals combining patient care with biomedical research or enjoying periods of intensive1
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
The award, granted by the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands, recognizes Novials' research career in the fi1
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labord1
Aleix Prat is leading the research, which focuses on discovering new ways of diagnosing hormone receptor-positive breast cancer, as well as new thera1
Understanding the mechanisms involved in ulcerative colitis and Crohn disease and identifying new therapeutic targets and markers for response to tre1
Researchers from Hospital Clínic-IDIBAPS have participated in an international collaboration led by IBEC in which they have generated human mini-kidn1
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioratio1
